cmv

  1. forestglip

    Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study, 2021, Grut et al

    Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study Viktor Grut, Martin Biström, Jonatan Salzer, Pernilla Stridh, Daniel Jons, Rasmus Gustafsson, Anna Fogdell-Hahn, Jesse Huang, Nicole Brenner, Julia Butt, Noemi Bender, Anna...
  2. Mij

    Immunological and clinical markers of PASC: Insights from mild and severe cases six months post-infection, 2025, William Mouton et al

    Abstract Post-acute sequelae of COVID-19 (PASC) is a complex and multifaceted clinical challenge requiring to emphasize its underlying pathophysiological mechanisms. This study assessed hundreds of virological, serological, immunological, and tissue damage biomarkers in two patient cohorts who...
  3. SNT Gatchaman

    Association Between NK Cell Genetic Variants and the Development of Long COVID Associated- and Prepandemic Small Fiber Neuropathy, 2024, Graninger+

    Association Between NK Cell Genetic Variants and the Development of Long COVID Associated- and Prepandemic Small Fiber Neuropathy Marianne Graninger; Verena Endmayr; Laura M. Kühner; Sarah M. Berger; Paulus Rommer; Sigrid Klotz; Ellen Gelpi; Hannes Vietzen; Romana Höftberger; Elisabeth...
  4. SNT Gatchaman

    [NF-κB], interferon regulatory Factor, and glucocorticoid receptor pathway activation in [depression]: The role of [CMV], 2024, Savitz+

    Nuclear factor kappa-B cell NF-κB, interferon regulatory Factor, and glucocorticoid receptor pathway activation in major depressive Disorder: The role of cytomegalovirus infection Savitz; McKinney; Meier; Zheng; Ford; Yolken; Teague; Cole Altered activity of major immunoregulatory pathways has...
  5. SNT Gatchaman

    Preprint Sex differences in symptomatology and immune profiles of Long COVID, 2024, Silva, Putrino, Iwasaki et al.

    Sex differences in symptomatology and immune profiles of Long COVID Julio Silva; Takehiro Takahashi; Jamie Wood; Peiwen Lu; Sasha Tabachnikova; Jeffrey Gehlhausen; Kerrie Greene; Bornali Bhattacharjee; Valter Silva Monteiro; Carolina Lucas; Rahul Dhodapkar; Laura Tabacof; Mario Pena-Hernandez...
  6. SNT Gatchaman

    Preprint Genome-wide association study reveals different T cell distributions in blood of individuals at high genetic risk of type 1 diabetes & LC,2024,Deecke+

    Genome-wide association study reveals different T cell distributions in peripheral blood of healthy individuals at high genetic risk of type 1 diabetes and long COVID Laura Deecke; Jan Homann; David Goldeck; Felix Luessi; Marijne Vandebergh; Olena Ohlei; Sarah Toepfer; Frauke Zipp; Ilja Demuth...
  7. Midnattsol

    Hypothesis Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis, 2023, Vietzen et al.

    I wasn't sure what prefix to use given that the paper has been accepted in Cell but not published. I read about it in a paywalled news article as the abstract was presented at the ECTRIMS 2023. Ineffective Immune Control of Epstein-Barr Virus-Induced Autoreactive Responses is an Important Cause...
  8. SNT Gatchaman

    Latent virus reactivation in astronauts on the international space station, 2017, Mehta et al.

    Latent virus reactivation in astronauts on the international space station Mehta, Satish K.; Laudenslager, Mark L.; Stowe, Raymond P.; Crucian, Brian E.; Feiveson, Alan H.; Sams, Clarence F.; Pierson, Duane L. Reactivation of latent herpes viruses was measured in 23 astronauts (18 male and 5...
  9. mango

    Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with [ME/CFS], 2022, Apostolou et al

    Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome Eirini Apostolou, Muhammad Rizwan, Petros Moustardas, Per Sjögren, Bo Christer Bertilson, Björn Bragée, Olli Polo and Anders...
  10. rvallee

    Development and testing of new vaccines against EBV and other viruses

    Moderna appears to be developing several mRNA vaccines for EBV and other viruses It's an investors' document but it lists several mRNA vaccines in various phases of development for some of the ME-causing viruses: CMV, EBV and some flu strains. CMV appears to be in phase 2 development. EBV could...
  11. P

    Anyone Treating the Eight Herpes Viruses with Antivirals?

    There are at least eight herpes virus variants that infect humans. These include: Human herpes virus 1 (HHV1) is also known as herpes simplex virus 1 (HSV1). Human herpes virus 2 (HHV2) is also called herpes simplex virus 2 (HSV2). Human herpes virus 3 (HHV3) is also called varicella-zoster...
Back
Top Bottom